Skip to main content
Jazz Pharmaceuticals plc (JAZZ)
NASDAQ: JAZZ · Real-Time Price · USD
203.98
+2.76 (1.37%)
At close: Apr 28, 2026, 4:00 PM EDT
188.98
-15.00 (-7.35%)
After-hours: Apr 28, 2026, 7:59 PM EDT

Jazz Pharmaceuticals Revenue

In the year 2025, Jazz Pharmaceuticals had annual revenue of $4.27B with 4.88% growth. Jazz Pharmaceuticals had revenue of $1.20B in the quarter ending December 31, 2025, with 10.09% growth.

Revenue (ttm)
$4.27B
Revenue Growth
+4.88%
P/S Ratio
2.94
Revenue / Employee
$1,476,673
Employees
2,890
Market Cap
12.56B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20254.27B198.64M4.88%
Dec 31, 20244.07B234.75M6.12%
Dec 31, 20233.83B174.83M4.78%
Dec 31, 20223.66B565.14M18.26%
Dec 31, 20213.09B730.67M30.91%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Genmab 3.72B
BioMarin Pharmaceutical 3.22B
Exelixis 2.32B
Arrowhead Pharmaceuticals 1.09B
Madrigal Pharmaceuticals 958.40M
Ionis Pharmaceuticals 943.71M
Ascendis Pharma 845.52M
Axsome Therapeutics 638.50M
Revenue Rankings

JAZZ News

More News